O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
Clinical trial NCT00669669 · TERMINATED
Trial details
- NCT number
- NCT00669669
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-25
- Primary completion
- 2018-07-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.